ViiV ‘actively negotiating’ voluntary licence for HIV prevention drug

May 27, 2022 |
Former Heads of State Urge U.S. to Commit $5 Billion to Global Covid Fight
ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...